Search - tctmd.com

Displaying 321 - 340 of 421

Presentation TCT 2013

Association of Acute Kidney Injury with Mortality post TAVR

Presenter: Elizabeth Holper, Ethan Ungchusri, Robert Farkas, Christina Worley, Morley Herbert, Wells Stewart, William Brinkman, David Brown

January 31, 2013

Presentation TCT 2013

A Preclinical Comparative Histological Evaluation of the Renal Artery and Nerves in the Human Cadaver and Swine model

Presenter: Radhika Tunstall, Dawn Winsor-Hines, Martin Willard, Barbara Huibregtse

January 31, 2013

Presentation TCT 2013

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Presenter: IMTIAZ KALYAR, James Gleeson, Sajjad Matiullah, Faisal Sharif

January 31, 2013

Presentation

Renal Sympathetic Denervation Does Not Aggravate Functional or Structural Renal Damage

Presenter: Oliver D?rr

January 08, 2013

Presentation

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Presenter: Murray Esler

December 19, 2012

Presentation ICI 2012

Vessix Renal Denervation System: Achieving Safety and Efficacy in Less Than One Minute

Presenter: James R. Margolis

December 02, 2012

Presentation

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Presenter: Marc Dorenkamp

November 29, 2012

Presentation TCT 2012

Initiating a Renal Denervation Program

Presenter: George Dangas

October 25, 2012

Presentation TCT 2012

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Presenter: Deepak Bhatt

October 24, 2012

Presentation TCT 2012

Vincristine Local Delivery for Renal Artery Denervation

Presenter: Christodoulos Stefanadis

October 24, 2012

Presentation TCT 2012

V2 (Vessix Vascular)

Presenter: James Margolis

October 24, 2012

Presentation TCT 2012

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

Presenter: Renu Virmani

October 24, 2012

Presentation TCT 2012

TIVUS (CardioSonic)

Presenter: Dierk Scheinert

October 24, 2012

Presentation TCT 2012

Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us

Presenter: Michael Bohm

October 24, 2012

Presentation TCT 2012

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Presenter: Felix Mahfoud

October 24, 2012

Presentation TCT 2012

Systolic and Diastolic Heart Failure

Presenter: Justin Davies

October 24, 2012

Presentation TCT 2012

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

Presenter: Darrel Francis

October 24, 2012

Presentation TCT 2012

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Presenter: Vasilios Papademetriou

October 24, 2012

Presentation TCT 2012

Sound Intervention

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

Sham Trials Are Burdensome and Introduce Their Own Errors!

Presenter: Deepak Bhatt

October 24, 2012

Advertisement

Association of Acute Kidney Injury with Mortality post TAVR

A Preclinical Comparative Histological Evaluation of the Renal Artery and Nerves in the Human Cadaver and Swine model

A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland

Renal Sympathetic Denervation Does Not Aggravate Functional or Structural Renal Damage

Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension

Vessix Renal Denervation System: Achieving Safety and Efficacy in Less Than One Minute

Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension

Initiating a Renal Denervation Program

What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data

Vincristine Local Delivery for Renal Artery Denervation

V2 (Vessix Vascular)

Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy

TIVUS (CardioSonic)

Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us

The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry

Systolic and Diastolic Heart Failure

SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design!

Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical)

Sound Intervention

Sham Trials Are Burdensome and Introduce Their Own Errors!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content